TargED Raises €21.5M to Advance Targeted Clot Therapy Drugs
Amsterdam-based biotech startup TargED Biopharmaceuticals has taken a major step forward in its mission to improve treatment outcomes for patients with life-threatening thrombotic diseases. The company announced a €21.5 million…